There is now increasing medical evidence and patient testimony showing that a small but significant minority of people who contract and survive COVID-19 report chronic symptoms ranging from breathlessness, chronic fatigue, ‘brain fog’, anxiety and stress for months after initially falling ill.
These ongoing problems, commonly termed ‘Long COVID’, may be experienced by patients regardless of how severe their COVID-19 infection was and irrespective of whether they were hospitalised. NHS England has recently launched a plan to support ‘Long COVID’ patients in the community.
The NIHR and UK Research and Innovation (UKRI) are jointly funding major studies to characterise acute and longer term disease in hospitalised patients, for example the UK-wide ISARIC-4C and Post hospitalisation COVID-19 (PHOSP-COVID) study.
The NIHR and UKRI are now launching a UK-wide further joint research call of up to £20 million to fund ambitious and comprehensive research into understanding, mitigating and addressing the longer term, physical and mental health effects, of COVID-19 in non-hospitalised individuals.
Projects are expected to start early in the New Year and may be funded for up to 3 years in the first instance.
The call closes on 9 December
Click here for more information